| Metric | Value | Detail |
|---|---|---|
| Revenue | $447.6B | +11.8% YoY |
| Net income | $12.8B | 2.9% margin |
| Gross margin | n/a | Gross profit / revenue |
| Operating margin | 4.2% | Operating income / revenue |
| Return on equity | 13% | Net income / equity |
| Return on assets | 4% | Net income / assets |
| Revenue growth (YoY) | +11.8% | FY2024 to FY2025 |
| Revenue 3-yr CAGR | +11.4% | Compound annual |
| Diluted EPS | $13.28 | FY2025 |
| Debt-to-equity | 0.72 | Long-term debt / equity |
| Current ratio | 0.79 | Current assets / liabilities |
| Cash & equivalents | $24.4B | Balance sheet |
| Total assets | $309.6B | FY2025 year-end |
| Shareholders’ equity | $100.1B | FY2025 year-end |
| Share price | $424.62 | Delayed · 2026-07-10 |
| Market cap | $385.6B | Price × shares outstanding |
| P/E ratio | 30.1 | Market cap / net income |
| P/S ratio | 0.9 | Market cap / revenue |
| Dividend yield | 2.06% | Dividend / price |
Stock fundamentals · FY2025 · SEC 10-K data
UnitedHealth Group Incorporated (UNH) stock fundamentals
UnitedHealth Group Incorporated (UNH) reported $447.6B in revenue and $12.8B in net income in fiscal 2025, a 2.9% net margin, per its latest SEC 10-K filing. It carries a market capitalization of about $385.6B at a delayed share price. It scores 33/100 on WealthyBud's Investor Score, ranking #90 of 100 covered companies. Score is research, not investment advice.
Revenue (FY2025)
$447.6B
▲ +11.8% YoY
Net income
$12.8B
2.9% net margin
Market cap
$385.6B
Price $424.62 · delayed
P/E ratio
30.1
Price / earnings
Return on equity
13%
Net income / equity
Investor Score
33/100
#90 of 100 covered
UnitedHealth Group Incorporated fundamentals at a glance
The table summarizes UnitedHealth Group Incorporated's key financial figures for fiscal 2025 — revenue, profitability, returns, growth and balance-sheet strength — each taken from the company's SEC 10-K filing.
How profitable is UnitedHealth Group Incorporated?
UnitedHealth Group Incorporated runs a 2.9% net margin and n/a gross margin in fiscal 2025, turning $447.6B of revenue into $12.8B of profit. Return on equity is 13% and return on assets 4%.
Is UnitedHealth Group Incorporated growing?
UnitedHealth Group Incorporated's revenue changed +11.8% in fiscal 2025 and compounded at +11.4% a year over three years, reaching $447.6B. Diluted earnings per share were $13.28 for the year.
| Fiscal year | Revenue | Growth |
|---|---|---|
| 2021 | $287.6B | n/a |
| 2022 | $324.2B | +12.7% |
| 2023 | $371.6B | +14.6% |
| 2024 | $400.3B | +7.7% |
| 2025 | $447.6B | +11.8% |
How is UnitedHealth Group Incorporated valued?
UnitedHealth Group Incorporated carries a market capitalization of $385.6B at a delayed share price of $424.62, trading at a 30.1 price-to-earnings ratio and 0.9 price-to-sales with a 2.06% dividend yield. Its Value subscore is 64/100 across the covered universe.
How financially healthy is UnitedHealth Group Incorporated?
UnitedHealth Group Incorporated ended fiscal 2025 with $24.4B in cash, a debt-to-equity ratio of 0.72 and a current ratio of 0.79. Lower leverage and a current ratio above 1.0 signal a stronger balance sheet.
What is UnitedHealth Group Incorporated's Investor Score?
UnitedHealth Group Incorporated scores 33/100 on WealthyBud's Investor Score, #90 of 100 covered companies as of 2026-07-10. The score blends growth, profitability, returns on capital, balance-sheet strength and value into one percentile. It is a research opinion, not investment advice.
Investor Score
33/100
#90 of 100 covered companies
Subscores are percentile ranks (0–100) across the 100 covered companies, computed from the SEC fundamentals and delayed market price cited on this page. Data-derived opinion, not investment advice.
UnitedHealth Group Incorporated (UNH) stock FAQ
How much revenue does UnitedHealth Group Incorporated make?
UnitedHealth Group Incorporated (UNH) reported $447.6B in revenue in fiscal 2025, +11.8% versus the prior year, according to its SEC 10-K filing. Over the past three years its revenue has compounded at +11.4% a year.
Is UnitedHealth Group Incorporated profitable?
Yes. UnitedHealth Group Incorporated earned $12.8B in net income in fiscal 2025, a 2.9% net margin. Its return on equity was 13% and return on assets 4%, based on figures from its latest 10-K.
How fast is UnitedHealth Group Incorporated growing?
UnitedHealth Group Incorporated's revenue changed +11.8% year over year in fiscal 2025 and compounded at +11.4% annually over three years. Growth is one of four inputs to its WealthyBud Investor Score, scored 55/100 versus the covered universe.
What is UnitedHealth Group Incorporated's market cap and P/E ratio?
UnitedHealth Group Incorporated has a market capitalization of $385.6B at a delayed share price of $424.62, trading at a price-to-earnings ratio of 30.1 and price-to-sales of 0.9. Its dividend yield is 2.06%. Prices are delayed and illustrative.
What is UnitedHealth Group Incorporated's WealthyBud Investor Score?
UnitedHealth Group Incorporated scores 33/100, ranking #90 of 100 covered companies as of 2026-07-10. The score is a percentile blend of growth (55), profitability (6), returns on capital (22), balance-sheet strength (28) and value (64). It is a research opinion, not investment advice.
Where does this UnitedHealth Group Incorporated financial data come from?
Fundamentals come from UnitedHealth Group Incorporated's annual report (Form 10-K) filed with the SEC, via the public-domain EDGAR database. The share price used for market cap, P/E and yield is a delayed end-of-day quote, shown as illustrative; a production site would use a licensed real-time market-data feed.
Fundamentals are drawn from UnitedHealth Group Incorporated’s FY2025 Form 10-K filed with the
SEC (EDGAR, public domain), retrieved 2026-07-10. Share price is a delayed end-of-day quote; market cap, P/E, P/S
and dividend yield are illustrative and not real-time. The Investor Score is a data-derived research opinion.
Not investment advice.